Table 4.
Clinical Performance of Professional Continuous Glucose Monitoring by Congestive Heart Failure Status
| Non-CHF (%) | CHF (%) | P valuea | |
|---|---|---|---|
| Original EGA | |||
| Zone A | 86.7 | 79.3 | 0.001 |
| Zone A+B | 98.7 | 98.5 | >0.99 |
| CG-EGA | |||
| <70 mg/dL | |||
| Zone A | 100 | 12.5 | 0.01 |
| Zone A+B | 100 | 12.5 | 0.01 |
| Erroneous | 0 | 87.5 | 0.01 |
| 71–180 mg/dL | |||
| Zone A | 100 | 99.5 | >0.99 |
| Zone A+B | 100 | 99.5 | >0.99 |
| Erroneous | 0 | 0.5 | >0.99 |
| >180 mg/dL | |||
| Zone A | 97.7 | 97.8 | >0.99 |
| Zone A+B | 97.7 | 97.8 | >0.99 |
| Erroneous | 2.3 | 2.2 | >0.99 |
a
Differences between groups were determined using Fisher's exact test.
CG-EGA, continuous glucose error grid analysis; CHF, congestive heart failure; EGA, error grid analysis.